| Brand |
Eata Marisource |
| Product Grade |
Pharmaceutical Grade |
| Chemical Name |
D-Glucosamine hydrochloride |
| Molecular Formula |
C6H13NO5·HCl |
| Raw Material Source |
Hydrolyzed chitin from crustacean shell |
| Physical Form |
Crystalline powder |
| Appearance |
White crystalline powder |
| Color |
White |
| Odor |
Odorless |
| Taste |
Slightly sweet, saline finish |
| pH Value |
3.5-5.0 (aqueous solution) |
| Solubility |
Freely soluble in water; practically insoluble in ethanol |
| Water Solubility |
Freely soluble in water |
| Solubility in Organic Solvents |
Practically insoluble in ethanol |
| Moisture (Loss on Drying) |
0.5% max (loss on drying) |
| Ash Content |
0.1% max (residue on ignition) |
| Assay / Purity |
98.0-102.0% |
| Lead (Pb) |
Heavy metals (as Pb): 10 ppm max |
| Arsenic (As) |
3 ppm max |
| Heavy Metals (as Pb) |
Chloride: 16.2-16.7% |
| Total Plate Count |
1000 cfu/g max |
| Yeast and Mold |
100 cfu/g max |
| E. coli / Coliforms |
E. coli: Not detected
Staphylococcus aureus: Not detected
Salmonella: Not detected |
| Storage Temperature |
Ambient, dry |
| Storage Conditions |
Sealed, dry and clean storage away from contaminants |
| Allergen & Dietary Statement |
Derived from crustacean shell chitin |
| Intended Use |
Pharmaceutical raw material for osteoarthritis actives and premium supplements |
| Target Industries |
Pharmaceutical, dietary supplements |
| Recommended Applications |
API-adjacent joint-health actives, premium supplement lines |
| Handling & Safety |
Handle under pharma-warehouse discipline |
| Chemical Class |
Amino monosaccharide hydrochloride |
| Structural Unit |
2-amino-2-deoxy-D-glucose hydrochloride |
| Functional Groups |
Protonated amine, hydroxyls |
| Ionic Character |
Ammonium chloride salt |
| Key Features |
Pharma-grade assay window; rotation and chloride co-specified; complete pathogen panel |
| Functional Benefits |
Documentation depth suited to regulatory dossiers; consistent optical purity |
| Mechanism of Action |
Glucosamine substrate delivery for glycosaminoglycan synthesis |
| Typical End Products |
Joint-health pharmaceuticals and premium supplements |
| Formulation Compatibility |
Compatible with standard pharma excipients |
| Preparation & Dissolution Guidance |
Dissolve directly in aqueous phase |
| Reactivity & Derivatization |
Amine accessible after neutralization |
| Stability Notes |
Stable dry crystals |
| Usage Precautions |
Standard pharma contamination control |
| Environmental Profile |
Marine chitin valorization |
| Analytical Methods |
Assay by HPLC; rotation by polarimetry; chloride by titration; IR identity check |